Anest. intenziv. Med. 2025;36(5):342-345 | DOI: 10.36290/aim.2025.065

Year 2025 in review - SepsisReview Article

Karvunidis T., Královcová M.
Jednotka intenzivní péče, I. interní klinika Fakultní nemocnice Plzeň, Lékařská fakulta a Biomedicínské centrum v Plzni, Univerzita Karlova

This year's overview offers an objective and critical discussion as well as the authors' subjective perspective and commentary on selected publications in the field of sepsis, particularly regarding their relevance to everyday bedside clinical practice. The studies discussed include the REMAP-CAP Corticosteroid Domain RCT, SCREEN, ADAPT-Sepsis, and HELLO trials.

Keywords: sepsis, diagnosis, corticosteroids, biomarkers, antimicrobial treatment, burnout syndrome.

Received: November 3, 2025; Revised: December 11, 2025; Accepted: December 14, 2025; Published: December 22, 2025  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Karvunidis T, Královcová M. Year 2025 in review - Sepsis. Anest. intenziv. Med. 2025;36(5):342-345. doi: 10.36290/aim.2025.065.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 40 CZK (1.7 EUR)
    will be unlocked 22.12.2026

    References

    1. Meyer NJ, Prescott HC. Sepsis and Septic Shock. N Engl J Med. 2024;391(22):2133-2146. doi: 10.1056/NEJMra2403213. Go to original source... Go to PubMed...
    2. Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA. 2016;315(8):801-810. doi: 10.1001/jama.2016.0287. Go to original source... Go to PubMed...
    3. Klein Klouwenberg PMC, Cremer OL, van Vught LA, Ong DS, Frencken JF, Schultz MJ, et al. Likelihood of infection in patients with presumed sepsis at the time of intensive care unit admission: a cohort study. Crit Care. 2015;19(1):319. doi: 10.1186/s13054-015-1035-1. Go to original source... Go to PubMed...
    4. Nannan Panday RS, Lammers EMJ, Alam N, Nanayakkara PWB. An overview of positive cultures and clinical outcomes in septic patients: a sub-analysis of the Prehospital Antibiotics Against Sepsis (PHANTASi) trial. Crit Care. 2019;23(1):182. doi: 10.1186/s13054-019-2431-8. Go to original source... Go to PubMed...
    5. Rudd KE, Johnson SC, Agesa KM, Shackelford KA, Tsoi D, Rhodes Kievlan D, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study. Lancet. 2020;395(10219):200-211. doi: 10.1016/S0140-6736(19)32989-7. Go to original source... Go to PubMed...
    6. Meduri GU, Shih M-C, Bridges L, Martin TJ, El-Solh A, Seam N, et al. Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia. Intensive Care Med. 2022;48(8):1009-1023. doi: 10.1007/s00134-022-06684-3. Go to original source... Go to PubMed...
    7. Dequin P-F, Meziani F, Quenot J-P, Kamel T, Ricard J-D, Badie J, et al. Hydrocortisone in Severe Community-Acquired Pneumonia. N Engl J Med. 2023;388(21):1931-1941. doi: 10.1056/NEJMoa2215145. Go to original source... Go to PubMed...
    8. Karvunidis T. Year 2023 in review - Sepsis. Anesteziol a Intenziv Med. 2023;34(5):204-207. doi: 10.36290/aim.2023.048. Go to original source...
    9. Jones BE, Ramirez JA, Oren E, Soni NJ, Sullivan LR, Restrepo MI, et al. Diagnosis and Management of Community-acquired Pneumonia. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. Published online July 2025. doi: 10.1164/rccm.202507-1692ST. Go to original source... Go to PubMed...
    10. Chaudhuri D, Nei AM, Rochwerg B, Balk RA, Asehnoune K, Cadena R, et al. 2024 Focused Update: Guidelines on Use of Corticosteroids in Sepsis, Acute Respiratory Distress Syndrome, and Community-Acquired Pneumonia. Crit Care Med. 2024;52(5):e219-e233. doi: 10.1097/CCM.0000000000006172. Go to original source... Go to PubMed...
    11. Heming N, Berry L, Lorenzi E, et al. Effect of hydrocortisone on mortality in patients with severe community-acquired pneumonia. Intensive Care Med. 2025;51(4):665-680. doi: 10.1007/s00134-025-07861-w. Go to original source... Go to PubMed...
    12. Arabi YM, Alsaawi A, Alzahrani M, Al Khathaami AM, AlHazme RH, Al Mutrafy A, et al. Electronic Sepsis Screening Among Patients Admitted to Hospital Wards: A Stepped-Wedge Cluster Randomized Trial. JAMA. 2025;333(9):763-773. doi: 10.1001/jama.2024.25982. Go to original source... Go to PubMed...
    13. Andriolo BNG, Andriolo RB, Salomão R, Atallah ÁN. Effectiveness and safety of procalcitonin evaluation for reducing mortality in adults with sepsis, severe sepsis or septic shock. Cochrane Database Syst Rev. 2017;(1). doi: 10.1002/14651858.CD010959.pub2. Go to original source... Go to PubMed...
    14. Dark P, Hossain A, McAuley DF, Brealey D, Carlson G, Clayton JC, et al. Biomarker-Guided Antibiotic Duration for Hospitalized Patients With Suspected Sepsis: The ADAPT-Sepsis Randomized Clinical Trial. JAMA. 2025;333(8):682-693. doi: 10.1001/jama.2024.26458. Go to original source... Go to PubMed...
    15. Azoulay É, Myatra SN, Heras La Calle G, Jaber S, Boulanger C, Demirkýran O, et al. Positive communication for decreasing burnout in intensive-care-unit staff: a cluster-randomized trial. Intensive Care Med. 2025;51(11):2031-2041. doi: 10.1007/s00134-025-08134-2. Go to original source... Go to PubMed...

    Return to the content


    Anesteziologie a intenzivní medicína

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.